A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44 Danièle GodelaineJavier CarrascoAline Van Pel Original Article 10 November 2006 Pages: 753 - 759
Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2 Kousaku MimuraKoji KonoHideki Fujii Original Article 04 November 2006 Pages: 761 - 770
Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasion Yoshihiko KanoKuniyasu SodaFumio Konishi Original Article 14 September 2006 Pages: 771 - 781
Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins Mieun LeeClaudia KistlerStefan B. Eichmüller Original Article 07 November 2006 Pages: 783 - 795
Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy Xiaohui PengJohn TremlYvonne Paterson Original Article 11 November 2006 Pages: 797 - 806
Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family Xiao-Fei WangWilliam M. CohenBernard Maillère Original Article 20 September 2006 Pages: 807 - 818
Individual Vγ2-Jγ1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens Andrew M. HebbelerCristiana CairoC. David Pauza Original Article 28 November 2006 Pages: 819 - 829
Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke Léa-Isabelle ProulxGuillaume ParéElyse Y. Bissonnette Original Article 10 November 2006 Pages: 831 - 838
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer Pedro M. S. AlvesNicole LévyFrédéric Lévy Original Article 08 September 2006 Pages: 839 - 847
Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitro Jinfei ChenAnita SchmittMichael Schmitt Original Article 29 September 2006 Pages: 849 - 861
Immunization of Rhesus monkeys with a SialylTn–mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cells Ralf KircheisPetra SieglAndreas Nechansky Original Article 29 September 2006 Pages: 863 - 873
The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGβ by DNA immunization Qing Dong GuanYing WangSi Dong Xiong Original Article 04 November 2006 Pages: 875 - 884
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells Laura E. JohnsonThomas P. FryeDouglas G. McNeel Original Article 11 November 2006 Pages: 885 - 895
Antigen-independent immune responses after dendritic cell vaccination Nicolai LeonhartsbergerReinhold RamonerMartin Thurnher Original Article 15 November 2006 Pages: 897 - 903
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer Koji ObaSatoshi TeramukaiJunichi Sakamoto Original Article 15 November 2006 Pages: 905 - 911
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005 Elisabeth ErsværPeter HampsonØystein Bruserud Original Article 08 November 2006 Pages: 913 - 925
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines Reshma SinghYvonne Paterson Original Article 28 November 2006 Pages: 927 - 938
Cellular therapy of cancer symposium December 2nd–3rd 2006 Manchester, UK Fiona C. ThistlethwaiteDavid E. GilhamRobert E. Hawkins Meeting Report 27 February 2007 Pages: 939 - 942